日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

出版商更正:突变型 KRAS 疫苗联合双重免疫检查点阻断治疗切除胰腺癌:一项 I 期试验

Huff, Amanda L; Haldar, S Daniel; Girgis, Alexander A; Wang, Hejia Henry; Danilova, Ludmila; Heumann, Thatcher; Berg, Maureen; Wang, Yuxuan; Andaloori, Lalitya; Hernandez, Alexei; Longway, Gabriella; Barrett, Benjamin; Zhu, Zirui; Davis-Marcisak, Emily; Thoburn, Christopher; Leatherman, James; Mitchell, Sarah; Lee, Jae W; Shu, Daniel H; Konig, Maximillian F; Mog, Brian J; Montagne, Janelle; Coyne, Erin M; Bever, Katherine; Baretti, Marina; Yarchoan, Mark; Anders, Robert A; Kagohara, Luciane T; Laheru, Daniel; Thomas, Amy M; Durham, Jennifer; Nauroth, Julie M; Lu, Jiayun; Wang, Hao; Fertig, Elana J; Ho, Won Jin; Azad, Nilofer S; Jaffee, Elizabeth M; Zaidi, Neeha

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.

突变型 KRAS 疫苗联合双重检查点阻断治疗切除的胰腺癌:一项 I 期试验。

Huff Amanda L, Haldar S Daniel, Gergis Alexander A, Wang Hejia Henry, Danilova Ludmila, Heumann Thatcher, Berg Maureen, Wang Yuxuan, Andaloori Lalitya, Hernandez Alexei, Longway Gabriella, Barrett Benjamin, Zhu Zirui, Davis-Marcisak Emily, Thoburn Christopher, Leatherman James, Mitchell Sarah, Lee Jae W, Shu Daniel H, Konig Maximillian F, Mog Brian J, Montagne Janelle, Coyne Erin M, Bever Katherine, Baretti Marina, Yarchoan Mark, Anders Robert A, Kagohara Luciane T, Laheru Daniel, Thomas Amy M, Durham Jennifer, Nauroth Julie M, Lu Jiayun, Wang Hao, Fertig Elana J, Ho Won Jin, Azad Nilofer S, Jaffee Elizabeth M, Zaidi Neeha

Mast cells promote pathology and susceptibility in tuberculosis

肥大细胞促进结核病的病理发展和易感性

Gupta, Ananya; Taneja, Vibha; Rangel-Moreno, Javier; Naqvi, Nilofer; Abhimanyu; Tao, Yun; Ahmed, Mushtaq; Chauhan, Kuldeep Singh; de Leon, Daniela Trejo-Ponce; Ramírez-Martínez, Gustavo; Jiménez-Alvarez, Luis; Luna-Rivero, Cesar; Zuniga, Joaquin; Kaushal, Deepak; Khader, Shabaana A

Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials

拓宽入组门槛:胰腺癌和胆道癌试验中潜在可修改的研究入组标准分析

Saj, Fen; Namayanja, Felicity K; Xiao, Lianchun; Borad, Mitesh J; Kelley, Robin Kate; Goyal, Lipika; Azad, Nilofer S; Bachini, Melinda; Lindsey, Stacie; Pant, Shubham; Valle, Juan W; Fashoyin-Aje, Lola A; Javle, Milind

Timing of ileocolic resection for Crohn's disease: A survey of the patient perspective in the 'biological' era

克罗恩病回结肠切除术的时机选择:生物学时代患者视角的调查

Husnoo, Nilofer; Nongrum, Ruchika; Hall, Thomas; Whitman, Alexandra E; Wyld, Lynda; Lobo, Alan J; Morgan, Jenna L; Hawkins, Deborah; Brown, Steven R

Emerging Burden of Scrub Typhus: A Comprehensive Analysis of Clinical, Demographic, and Occupational Risk Factors in a Tertiary Care Center in Rajasthan, India

印度拉贾斯坦邦一家三级医疗中心恙虫病负担日益加重:临床、人口统计学和职业风险因素的综合分析

Sherawat, Pinky; Panda, Jitendra; Sharma, Shiv Prakash; Khayyam, Nilofer Sr

Perceptions and experiences of receptive anal intercourse among women: a systematic review and thematic analysis

女性对接受式肛交的认知和体验:系统综述和主题分析

Gana, Tabitha; Husnoo, Nilofer; Dev, Vidiya; Hunt, Lesley; Limmer, Mark; Mateus, Ceu

EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer

EGFR介导的局部侵袭性和对西妥昔单抗治疗头颈癌的反应

Jiefu Zhou # ,Min He # ,Qiong Zhao # ,Enxian Shi # ,Hairong Wang ,Vaidehi Ponkshe ,Jiahang Song ,Zhengquan Wu ,Dongmei Ji ,Gisela Kranz ,Anna Tscherne ,Sabina Schwenk-Zieger ,Nilofer Abdul Razak ,Julia Hess ,Claus Belka ,Horst Zitzelsberger ,Iordanis Ourailidis ,Fabian Stögbauer ,Melanie Boxberg ,Jan Budczies ,Christoph A Reichel ,Martin Canis ,Philipp Baumeister ,Hongxia Wang ,Kristian Unger ,Andreas Mock ,Olivier Gires

Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma

肿瘤部位影响胆管癌临床前模型中MEK抑制剂和免疫疗法联合治疗的疗效

Hammons, Jacklyn N; Warren, Emilie K; Wittling, Megen C; Bennett, Frances J; Rangel-Rivera, Guillermo O; Mack, Alexis F; Phillips, Maggie J; Robinson, Brian S; Krasinskas, Alyssa M; Horvat, Natalie K; Ruffin, Ayana T; Liu, Yuan; Cao, Yichun; Azad, Nilofer N S; Yarchoan, Mark M; Heumann, Thatcher; Keler, Tibor; Maithel, Shishir K; Paulos, Chrystal M; Lesinski, Gregory B

Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma.

肿瘤来源的 CCL2 驱动 IDH1 突变型胆管癌的肿瘤生长和免疫抑制

Zabransky Daniel J, Kartalia Emma, Lee Jae W, Leatherman James M, Charmsaz Soren, Young Sara E, Chhabra Yash, Franch-Expósito SebastiÃ, Kang Martin, Maru Saumya, Rastkari Noushin, Davis Michael, Dalton William Brian, Oshima Kiyoko, Baretti Marina, Azad Nilofer S, Jaffee Elizabeth M, Yarchoan Mark